Commonly assessed in BCP-ALL genetic aberrations: ETV6::RUNX1 fusion gene, PBX and KMT2A rearrangement are more frequent in patients without CD66c expression. The gene discussed is CEACAM6; the disease is acute lymphoblastic leukemia.